Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy.
Kuo CH, Wang SS, Hsu WH, Kuo FC, Weng BC, Li CJ, Hsu PI, Chen A, Hung WC, Yang YC, Wang WM, Wu DC.
Kuo CH, et al. Among authors: hsu wh, hsu pi.
Helicobacter. 2010 Aug;15(4):265-72. doi: 10.1111/j.1523-5378.2010.00761.x.
Helicobacter. 2010.
PMID: 20633187
Clinical Trial.